Accès ouvert
2026
article
OpenAlex
Anthony J. Farchione, HoChan Cheon, David Vremec, Julika Neumann et autres
Abstract T cells integrate signals from antigen and costimulatory receptors to calibrate response magnitude and quality, with genetically encoded programs shaping activation thresholds for immune tolerance and feedback regulation. Coeliac disease (CeD) is an autoimmune disorder with well‐defined genetic risk and immune …
au
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Matthew C Wierzbowski, HoChan Cheon, Ken R. Duffy, Susanne Heinzel et autres
Immunoglobulin class switch recombination by B lymphocytes requires the simultaneous expression of activation-induced cytidine deaminase (AID) and noncoding germline transcripts (GLT). Expression of both components is controllable through cytokine signalling and arise through stochastic mechanisms linked to cell division that can be …
au, us
(code pays fourni par la source)
Accès ouvert
2025
preprint
OpenAlex
Anthony J. Farchione, HoChan Cheon, David Vremec, Julika Neumann et autres
Abstract T cells integrate signals from antigen and co-stimulatory receptors to calibrate the strength and quality of their responses. This signal integration is influenced by genetic background, which can modulate thresholds for immune tolerance and strength of responses to threat. Celiac disease …
au
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
John E. La Marca, Brandon J. Aubrey, Bruce Yang, Catherine W.T. Chang et autres
Whole-genome screens using CRISPR technologies are powerful tools to identify novel tumour suppressors as well as factors that impact responses of malignant cells to anti-cancer agents. Applying this methodology to lymphoma cells, we conducted a genome-wide screen to identify novel inhibitors of …
au, us
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Melissa Biemond, David Vremec, Daniel H.D. Gray, Philip D. Hodgkin et autres
Abstract Programmed death receptor 1 (PD‐1) is an inhibitory receptor on T cells shown to restrain T‐cell proliferation. PD‐1 immune checkpoint blockade has emerged as a highly promising approach in cancer treatment. Much of our understanding of the function of PD‐1 is …
au
(code pays fourni par la source)
Accès ouvert
2023
preprint
OpenAlex
Michelle Ruhle, Evan A. Thomas, Edward Dann, Nicole Gottscheber et autres
ABSTRACT When stimulated, individual lymphocytes program times for division and death that are inherited within families, revealing a common timing mechanism transmitted over generations. Here we describe a threshold-based mechanism for the time to die. By comparing protein levels in control and …
au
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Susanne Heinzel, HoChan Cheon, Gabrielle T. Belz, Philip D. Hodgkin
Abstract Memory T cells are generated from naïve precursors undergoing proliferation during the initial immune response. Both naïve and memory T cells are maintained in a resting, quiescent state and respond to activation with a controlled proliferative burst and differentiation into effector …
au
(code pays fourni par la source)
Accès ouvert
2023
preprint
OpenAlex
Marco J. Herold, John E. La Marca, Brandon J. Aubrey, Bruce Yang et autres
au, us
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Miles B. Horton, HoChan Cheon, Ken R. Duffy, Daniel V. Brown et autres
au, ie
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
HoChan Cheon, Andrey Kan, Giulio Prevedello, Simone C. Oostindie et autres
Lymphocytes are the central actors in adaptive immune responses. When challenged with antigen, a small number of B and T cells have a cognate receptor capable of recognising and responding to the insult. These cells proliferate, building an exponentially growing, differentiating clone …
ie, au, gb
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
IY Kong, JS Rimes, A Light, I Todorovski et autres
© 2020 The Authors JQ1 is a BET-bromodomain inhibitor that has immunomodulatory effects. However, the precise molecular mechanism that JQ1 targets to elicit changes in antibody production is not understood. Our results show that JQ1 induces apoptosis, reduces cell proliferation, and as …
Accès ouvert
2020
article
OpenAlex
IY Kong, JS Rimes, A Light, I Todorovski et autres
© 2020 The Authors JQ1 is a BET-bromodomain inhibitor that has immunomodulatory effects. However, the precise molecular mechanism that JQ1 targets to elicit changes in antibody production is not understood. Our results show that JQ1 induces apoptosis, reduces cell proliferation, and as …